arginine has been researched along with carbostyril in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (53.85) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, K; Hashimoto, J; Imai, Y; Minami, N | 1 |
Kessler, T; Lugnier, C | 1 |
Abe, Y; Fujisawa, Y; Miyanaka, H; Miyatake, A; Mori, N; Yube, K | 1 |
Chu, CP; Jin, QH; Kannan, H; Kato, K; Oiso, Y; Qiu, DL; Yu, NS | 1 |
Bax, BD; Brown, KK; Chan, PF; Eggleston, DS; Fosberry, A; Gentry, DR; Giordano, I; Gorrec, F; Gwynn, MN; Hann, MM; Hennessy, A; Hibbs, M; Huang, J; Jones, E; Jones, J; Lewis, CJ; May, EW; Pearson, ND; Saunders, MR; Shen, C; Shillings, A; Singh, O; Spitzfaden, CE; Theobald, AJ; Wohlkonig, A | 1 |
Medico, CJ; Walsh, P | 1 |
Kim, KY; Kwak, HS; Park, JH; Woo, GJ | 1 |
Ahmadi, S; Bartlett, C; Bear, CE; Gonska, T; Ip, W; Jiang, J; Laselva, O; Lew, A; Moraes, TJ; Ouyang, H; Wellhauser, L; Wu, YS; Xia, S | 1 |
Kmiec, EB; To, RQ | 1 |
Chung, IK; Gootz, TD; McGuirk, PR; Muller, MT; Spitzner, JR | 1 |
Chu, DT; Clement, JJ; Permana, PA; Plattner, JJ; Shen, LL; Snapka, RM | 1 |
Coughlin, SA; Evans, AC; Huff, AC; Rake, JB; Robinson, RG; Selander, KN; Wentland, MP | 1 |
Gruger, T; Heisig, P; Maxwell, A; Nitiss, JL; Pommier, Y; Seeber, S; Strumberg, D; Zechiedrich, EL | 1 |
1 review(s) available for arginine and carbostyril
Article | Year |
---|---|
Pharmacotherapy in the critically ill obese patient.
Topics: Aminoglycosides; Antithrombins; Arginine; Body Mass Index; Carbapenems; Cephalosporins; Drug Dosage Calculations; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Hypnotics and Sedatives; Lipopeptides; Obesity; Oxazolidinones; Penicillins; Pipecolic Acids; Protein C; Quinolones; Recombinant Proteins; Safety; Sulfonamides; Vancomycin | 2010 |
12 other study(ies) available for arginine and carbostyril
Article | Year |
---|---|
Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Pressure; Captopril; Endothelium, Vascular; Heart Rate; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentolinium Tartrate; Piperidines; Quinolones; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1995 |
Rolipram increases cyclic GMP content in L-arginine-treated cultured bovine aortic endothelial cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Analysis of Variance; Animals; Aorta; Arginine; Cattle; Cells, Cultured; Cyclic AMP; Cyclic GMP; Drug Interactions; Endothelium, Vascular; Exonucleases; Indomethacin; Nitric Oxide; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinolones; Rolipram | 1995 |
Role of nitric oxide in regulation of renal sympathetic nerve activity during hemorrhage in conscious rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine; Blood Pressure; Consciousness; Enzyme Inhibitors; Heart Rate; Hemorrhage; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 1999 |
Enhanced cardiovascular alteration and Fos expression induced by central salt loading in a conscious rat transgenic for the metallothionein-vasopressin fusion gene.
Topics: Animals; Animals, Genetically Modified; Antidiuretic Hormone Receptor Antagonists; Arginine; Brain; Cardiovascular System; Consciousness; Immunohistochemistry; Injections, Intraventricular; Male; Metallothionein; Oncogene Proteins v-fos; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Recombinant Fusion Proteins; Saline Solution, Hypertonic; Sodium Chloride; Vasopressins | 2005 |
Type IIA topoisomerase inhibition by a new class of antibacterial agents.
Topics: Anti-Bacterial Agents; Apoenzymes; Arginine; Aspartic Acid; Binding Sites; Catalytic Domain; Ciprofloxacin; Crystallography, X-Ray; DNA; DNA Cleavage; DNA Gyrase; DNA, Superhelical; Drug Design; Drug Resistance; Escherichia coli; Manganese; Models, Molecular; Protein Conformation; Quinolines; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2010 |
Characterization of the quinolone resistance mechanism in foodborne Salmonella isolates with high nalidixic acid resistance.
Topics: Anti-Infective Agents; Arginine; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Food Microbiology; Meat; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Plasmids; Quinolones; Republic of Korea; Salmonella enterica | 2011 |
ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channe
Topics: Aminophenols; Aminopyridines; Animals; Arginase; Arginine; Benzodioxoles; Bronchi; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytosol; Drug Combinations; Humans; Intestinal Mucosa; Mice; Mutation; Nitric Oxide; Nose; Quinolones | 2019 |
Assembly of transcriptionally active chromatin in vitro: a possible role for topoisomerase II.
Topics: Adenosine Triphosphate; Animals; Anti-Infective Agents; Cell-Free System; Chromatin; DNA Topoisomerases, Type II; DNA, Circular; DNA, Superhelical; Enrofloxacin; Fluoroquinolones; Gene Expression Regulation; Models, Genetic; Nucleosomes; Quinolones; Teniposide; Topoisomerase II Inhibitors; Transcription, Genetic; Xenopus laevis | 1990 |
Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
Topics: Amsacrine; Anti-Infective Agents; Base Sequence; DNA; DNA Topoisomerases, Type II; Etoposide; Fluoroquinolones; Humans; Hydrolysis; Molecular Sequence Data; Quinolones; Teniposide; Topoisomerase II Inhibitors | 1995 |
Quinobenoxazines: a class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitors.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cattle; Cell Line; Chlorocebus aethiops; DNA Replication; Doxorubicin; Kidney; Kinetics; Oxazines; Quinolones; Simian virus 40; Structure-Activity Relationship; Teniposide; Thymus Gland; Topoisomerase II Inhibitors | 1994 |
DNA sequence preferences at sites cleaved by human DNA topoisomerase II in response to novel quinolone derivatives.
Topics: Amsacrine; Base Sequence; DNA; DNA Topoisomerases, Type II; HeLa Cells; Humans; Hydrolysis; Molecular Sequence Data; Quinolones; Substrate Specificity; Teniposide; Topoisomerase II Inhibitors | 1995 |
A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase II.
Topics: Anti-Bacterial Agents; Chromosome Mapping; DNA Gyrase; DNA, Superhelical; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Etoposide; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Plasmids; Point Mutation; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Teniposide; Time Factors; Topoisomerase II Inhibitors | 2004 |